Description
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
Product Unit Size | Cost | Quantity | Stock |
---|
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
Cas No. | 1421373-98-9 |
---|---|
Purity | ≥98% |
Formula | C27H31N7O2 |
Formula Wt. | 485.59 |
IUPAC Name | N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-5-{[4-(1H-indol-3-yl)-2-pyrimidinyl]amino}-4-methoxyphenyl)acrylamide |
Synonym | AZ-5104, AZ 5104, AZ5104 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Yates J. Ashton S., et al. Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104. Mol Cancer Ther. 15(10):2378-87 (2016). PMID: 27439477.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
p53 inhibitor
Tetrapeptide, binds cell surface integrins.
IGF-1R and InsR inhibitor.
Iridoid glucoside found in Cornus officialis; Î...
Nonpeptide angiotensin II receptor antagonist
Taxane synthesis intermediate.
Endogenous tachykinin peptide, involved in infl...
Synthetic derivative of selenocyanate.
N-Des-2-methylpropan-2-ol Docetaxel is an impur...
RIP1 inhibitor.
PARP1/2 inhibitor.
Spirodihydrobenzofuranlactam
Mycotoxin.
Zinc chelator
AT1 antagonist.
Natriuretic, vasodilatory peptide fragment; B1/...
Cyclic depsipeptide is a secondary metabolite i...
Hydrazine derivative, DNA alkylator; MAO inhibi...
Fluoroquinolone; topoisomerase IV and bacterial...